{"database": "lobbying", "table": "lobbying_activities", "rows": [[2018934, "8ac0c2fe-c42a-4d7c-bdf3-adcffac49bc2", "Q3", "RED+BLUE STRATEGIES", 400693064, "COHERUS BIOSCIENCES", 2017, "third_quarter", "PHA", "Work to reconsider current CMS position on the structure of the Medicare J-Code for biosimilar medications.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2017-09-27T16:38:57.697000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2018934"], "units": {}, "query_ms": 2.241199021227658, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}